Alyeska Investment Group, L.P. Catalent, Inc. Transaction History

Alyeska Investment Group, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $35.6 Million - $69.6 Million	858,977 New	858,977 $38.6 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $10.5 Million - $13 Million	103,900 Added 435.73%	127,745 $13.5 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $30.7 Million - $52.4 Million	-831,870 Reduced 97.21%	23,845 $1.24 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $252,476 - $303,873	-5,365 Reduced 0.62%	855,715 $48.2 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $14.1 Million - $17.3 Million	297,468 Added 52.78%	861,080 $41 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $20.4 Million - $28.1 Million	518,894 Added 1160.37%	563,612 $0
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $1.34 Million - $2.07 Million	44,718 New	44,718 $1.39 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.